| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |